RIZATRIPTAN RS rizatriptan (as benzoate) 10 mg orally disintegrating tablets blisters

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Dostępny od:

Arrotex Pharmaceuticals Pty Ltd

INN (International Nazwa):

rizatriptan benzoate

Forma farmaceutyczna:

Tablet, orally disintegrating

Skład:

Excipient Ingredients: acesulfame potassium; crospovidone; ethylcellulose; mannitol; hypromellose; silicon dioxide; sodium stearylfumarate; colloidal anhydrous silica; Flavour

Droga podania:

Sublingual

Sztuk w opakowaniu:

2, 6, 1, 3

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

for acute treatment of migraine attacks with or without aura.

Podsumowanie produktu:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C7' on one side and 'C' on the other side, having a characteristic flavour.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Licence status A

Data autoryzacji:

2015-03-20